factual
Biotech Is Avoided by Most World-Class Investors
The vast majority of world-class investors studied say biotech is the one area they will never enter because it is too complex and requires too much specialization, which is why the founders find it attractive.
factualpending
Speaker
Rick BuhrmanEvidence Quote
“the vast majority of world-class investors we've studied, it's the only area that they say they will never go”
Source
Rick Buhrman & Paul Buser - Find Your X, Nurture Your N - [Invest Like the Best, EP.346]— Invest Like the BestCreated: 11/18/2026, 11:38:41 PM
Your notes
Loading notes...